ERIS Lifesciences standalone net profit rises 39.38% in the September 2017 quarter

Sales rise 14.78% to Rs 222.06 crore
Net profit of ERIS Lifesciences rose 39.38% to Rs 92.30 crore in the quarter ended September 2017 as against Rs 66.22 crore during the previous quarter ended September 2016. Sales rose 14.78% to Rs 222.06 crore in the quarter ended September 2017 as against Rs 193.47 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales222.06193.47 15 OPM %42.9737.53 -PBDT102.3379.56 29 PBT97.8374.28 32 NP92.3066.22 39Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 20 2017 | 5:35 PM IST
